Haleon Plc Form 6-K Summary
Business Context and Reporting Period
This Form 6-K filing covers the period ending September 30, 2024. Haleon Plc is a global leader in consumer health with a portfolio spanning Oral Health, Pain Relief, Respiratory Health, Digestive Health, and Vitamins, Minerals, and Supplements (VMS). The company operates under the ticker symbols HLN (NYSE) and HLN (LSE).
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on capital structure and voting rights.
- Total Issued Shares with Voting Rights: 9,133,887,197 ordinary shares of £0.01 each.
- Treasury Shares: None.
Material Changes
The filing does not disclose material changes in financial performance or operations compared to prior periods. It serves as a notification of the total share count as of the reporting date for use in calculating notifiable interests under the Disclosure and Transparency Rules of the Financial Conduct Authority.
Guidance, Outlook, and Risks
The filing text does not provide a clear value for future guidance, management commentary on outlook, specific risks, contingencies, or unusual items. The document is a statutory disclosure regarding share capital.
Key Facts for Investor Verification
- Verify the total voting share count of 9,133,887,197 for compliance with notification thresholds.
- Confirm that no ordinary shares are held in treasury as of September 30, 2024.
- Note that this filing does not contain financial performance data; refer to Form 20-F or quarterly earnings releases for revenue and profit metrics.